Wenyin Shi

My research focuses on improving therapeutic ratio through innovative clinical trials. My interest is incorporating novel molecular targeting agents with radiation. My research includes a variety of different new agents, such as anti-angiogenic agents, vascular disrupting agents, signal transduction pathway inhibitors, and immune modulators. I have successfully developed several investigator-initiated clinical trials to evaluate such novel agents with radiation treatment.